Expanding roles for AMPK in skeletal muscle plasticity

Trends in Endocrinology and Metabolism

Volumn 26, Issue 6, 2015, Pages 275-286

  Mounier, Rémi ^a,b   Théret, Marine ^a,b,c   Lantier, Louise ^d   Foretz, Marc ^c,e,f   Viollet, Benoit ^c,e,f  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUT COCHIN   (France)

^f CNRS   (France)

Author keywords

AMP activated protein kinase; Exercise; Muscular diseases; Regeneration; Skeletal muscle; Therapeutics

Indexed keywords

FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ADAPTATION; AUTOPHAGY; CELL FATE; ENERGY BALANCE; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STRUCTURE; FATTY ACID OXIDATION; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORT; HUMAN; METABOLIC REGULATION; MUSCLE CONTRACTION; MUSCLE EXERCISE; MUSCLE INJURY; MUSCLE STEM CELL; NONHUMAN; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; TISSUE ENGINEERING; TISSUE REPAIR; ANIMAL; ENZYMOLOGY; EXERCISE; METABOLISM; MUSCLE DISEASE; PHYSIOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; EXERCISE; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 84930040691     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.02.009     Document Type: Review

References (121)

1. Bassel-Duby R., Olson E.N. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 2006, 75:19-37.
2. Fluck M. Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J. Exp. Biol. 2006, 209:2239-2248.
3. Hood D.A., et al. Coordination of metabolic plasticity in skeletal muscle. J. Exp. Biol. 2006, 209:2265-2275.
4. Hardie D.G. AMPK - sensing energy while talking to other signaling pathways. Cell Metab. 2014, 20:939-952.
5. Jensen T.E., et al. AMP-activated protein kinase in contraction regulation of skeletal muscle metabolism: necessary and/or sufficient?. Acta Physiol. (Oxf.) 2009, 196:155-174.
6. Jensen T.E., Richter E.A. Regulation of glucose and glycogen metabolism during and after exercise. J. Physiol. 2012, 590:1069-1076.
7. O'Neill H.M., et al. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity. Mol. Cell. Endocrinol. 2013, 366:135-151.
8. McGee S.L., Hargreaves M. Histone modifications and exercise adaptations. J. Appl. Physiol. (1985) 2011, 110:258-263.
9. McBride A., et al. The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab. 2009, 9:23-34.
10. Wojtaszewski J.F., et al. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E813-E822.
11. Sakamoto K., et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 2005, 24:1810-1820.
12. Thomson D.M., et al. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E196-E202.
13. Oakhill J.S., et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 2011, 332:1433-1435.
14. Xiao B., et al. Structure of mammalian AMPK and its regulation by ADP. Nature 2011, 472:230-233.
15. Cheung P.C., et al. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 2000, 346:659-669.
16. Suter M., et al. Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 2006, 281:32207-32216.
17. Hawley S.A., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
18. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
19. Jensen T.E., et al. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1308-E1317.
20. McGee S.L., et al. Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase α1 following overload in LKB1 knockout mice. J. Physiol. 2008, 586:1731-1741.
21. Birk J.B., Wojtaszewski J.F. Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle. J. Physiol. 2006, 577:1021-1032.
22. Treebak J.T., et al. A-769662 activates AMPK β1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 2009, 297:C1041-C1052.
23. Barnes B.R., et al. The 5'-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem. 2004, 279:38441-38447.
24. Milan D., et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 2000, 288:1248-1251.
25. Costford S.R., et al. Gain-of-function R225W mutation in human AMPKγ3 causing increased glycogen and decreased triglyceride in skeletal muscle. PLoS ONE 2007, 2:e903.
26. Treebak J.T., et al. AS160 phosphorylation is associated with activation of α2β2γ1- but not α2β2γ3-AMPK trimeric complex in skeletal muscle during exercise in humans. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E715-E722.
27. McGee S.L., et al. Exercise increases nuclear AMPK α2 in human skeletal muscle. Diabetes 2003, 52:926-928.
28. Treebak J.T., et al. Acute exercise and physiological insulin induce distinct phosphorylation signatures on TBC1D1 and TBC1D4 proteins in human skeletal muscle. J. Physiol. 2014, 592:351-375.
29. Warden S.M., et al. Post-translational modifications of the β-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 2001, 354:275-283.
30. Pinter K., et al. Localisation of AMPK gamma subunits in cardiac and skeletal muscles. J. Muscle Res. Cell Motil. 2013, 34:369-378.
31. Rockl K.S., et al. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 2007, 56:2062-2069.
32. Suwa M., et al. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. (1985) 2003, 95:960-968.
33. Reyes N.L., et al. Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 2014, 112:424-429.
34. Garcia-Roves P.M., et al. Gain-of-function R225Q mutation in AMP-activated protein kinase γ3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J. Biol. Chem. 2008, 283:35724-35734.
35. O'Neill H.M., et al. AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16092-16097.
36. Lantier L., et al. AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. FASEB J. 2014, 28:3211-3224.
37. Merrill G.F., et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273:E1107-E1112.
38. Winder W.W., Hardie D.G. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. 1996, 270:E299-E304.
39. Hutber C.A., et al. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am. J. Physiol. 1997, 272:E262-E266.
40. Vavvas D., et al. Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 1997, 272:13255-13261.
41. O'Neill H.M., et al. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia 2014, 57:1693-1702.
42. Roepstorff C., et al. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E133-E142.
43. Miura S., et al. α2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E47-E55.
44. Dzamko N., et al. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J. Physiol. 2008, 586:5819-5831.
45. Jeppesen J., et al. LKB1 regulates lipid oxidation during exercise independently of AMPK. Diabetes 2013, 62:1490-1499.
46. Jeppesen J., et al. Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent. J. Lipid Res. 2011, 52:699-711.
47. Fentz J., et al. AMPKα is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice. FASEB J. 2015, Published online January 21, 2015. 10.1096/fj.14-266650.
48. Richter E.A., Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol. Rev. 2013, 93:993-1017.
49. Szekeres F., et al. The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E524-E533.
50. Chadt A., et al. Deletion of both Rab-GTPase-activating proteins TBC1D1 and TBC1D4 in mice eliminates insulin- and AICAR-stimulated glucose transport. Diabetes 2015, 64:746-759.
51. Stockli J., et al. The RabGAP TBC1D1 plays a central role in exercise-regulated glucose metabolism in skeletal muscle. Diabetes 2015, Published online January 9, 2015. 10.2337/db13-1489.
52. Musi N., et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001, 50:921-927.
53. Musi N., et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002, 51:2074-2081.
54. Hayashi T., et al. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998, 47:1369-1373.
55. Jorgensen S.B., et al. Knockout of the α2 but not α1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 2004, 279:1070-1079.
56. Lai Y.C., et al. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Biochem. J. 2014, 460:363-375.
57. Pehmoller C., et al. Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E665-E675.
58. Treebak J.T., et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 2006, 55:2051-2058.
59. 2+-dependent mechanism in slow-twitch rat soleus muscle. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1062-E1066.
60. 2+ release. Mol. Metab. 2014, 3:742-753.
61. McGee S.L., Hargreaves M. AMPK-mediated regulation of transcription in skeletal muscle. Clin. Sci. (Lond.) 2010, 118:507-518.
62. Jager S., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12017-12022.
63. Canto C., et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010, 11:213-219.
64. McKinsey T.A., et al. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408:106-111.
65. McGee S.L., et al. Compensatory regulation of HDAC5 in muscle maintains metabolic adaptive responses and metabolism in response to energetic stress. FASEB J. 2014, 28:3384-3395.
66. Leick L., et al. PGC-1α is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E463-E474.
67. Zong H., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15983-15987.
68. Reznick R.M., et al. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 2007, 5:151-156.
69. Tanner C.B., et al. Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E1018-E1029.
70. Winder W.W., et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. (1985) 2000, 88:2219-2226.
71. Lee-Young R.S., et al. Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J. Biol. Chem. 2009, 284:23925-23934.
72. Mu J., et al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 2001, 7:1085-1094.
73. Grumati P., et al. Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for collagen VI-deficient muscles. Autophagy 2011, 7:1415-1423.
74. He C., et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481:511-515.
75. Sanchez A.M., et al. AMPK promotes skeletal muscle autophagy through activation of Forkhead FoxO3a and interaction with Ulk1. J. Cell. Biochem. 2012, 113:695-710.
76. Lo Verso F., et al. Autophagy is not required to sustain exercise and PRKAA1/AMPK activity but is important to prevent mitochondrial damage during physical activity. Autophagy 2014, 10:1883-1894.
77. Saclier M., et al. Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J. 2013, 280:4118-4130.
78. Saclier M., et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells 2013, 31:384-396.
79. Arnold L., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 2007, 204:1057-1069.
80. Jeong H.W., et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E955-E964.
81. Sag D., et al. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 2008, 181:8633-8641.
82. Zhao X., et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L497-L504.
83. Xing J., et al. Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo. Am. J. Pathol. 2013, 182:1021-1030.
84. Mounier R., et al. AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab. 2013, 18:251-264.
85. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
86. Yin H., et al. Satellite cells and the muscle stem cell niche. Physiol. Rev. 2013, 93:23-67.
87. Shan T., et al. Lkb1 is indispensable for skeletal muscle development, regeneration, and satellite cell homeostasis. Stem Cells 2014, 32:2893-2907.
88. Gopinath S.D., et al. FOXO3 promotes quiescence in adult muscle stem cells during the process of self-renewal. Stem Cell Rep. 2014, 2:414-426.
89. Christov C., et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol. Biol. Cell 2007, 18:1397-1409.
90. Abou-Khalil R., et al. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell 2009, 5:298-309.
91. Ylikorkala A., et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 2001, 293:1323-1326.
92. Simsek T., et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010, 7:380-390.
93. Rafalski V.A., et al. Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate. J. Cell Sci. 2012, 125:5597-5608.
94. +-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 2015, 16:171-183.
95. de Meester C., et al. Role of AMP-activated protein kinase in regulating hypoxic survival and proliferation of mesenchymal stem cells. Cardiovasc. Res. 2014, 101:20-29.
96. Zhu Z., et al. Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells through AMPK activation. PLoS ONE 2011, 6:e23554.
97. Alert. Nature 2014, 510:393-396.
98. Mounier R., et al. Important role for AMPKα1 in limiting skeletal muscle cell hypertrophy. FASEB J. 2009, 23:2264-2273.
99. Lantier L., et al. Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. FASEB J. 2010, 24:3555-3561.
100. Mounier R., et al. Antagonistic control of muscle cell size by AMPK and mTORC1. Cell Cycle 2011, 10:2640-2646.
101. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012, 8:457-465.
102. Carey A.L., et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006, 55:2688-2697.
103. Gray S.R., Kamolrat T. The effect of exercise induced cytokines on insulin stimulated glucose transport in C2C12 cells. Cytokine 2011, 55:221-228.
104. Huh J.Y., et al. Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J. Clin. Endocrinol. Metab. 2014, 99:E2154-E2161.
105. Shan T., et al. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J. 2013, 27:1981-1989.
106. Glund S., et al. Role of adenosine 5'-monophosphate-activated protein kinase in interleukin-6 release from isolated mouse skeletal muscle. Endocrinology 2009, 150:600-606.
107. Lauritzen H.P., et al. Contraction and AICAR stimulate IL-6 vesicle depletion from skeletal muscle fibers in vivo. Diabetes 2013, 62:3081-3092.
108. Ljubicic V., Jasmin B.J. AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy. Trends Mol. Med. 2013, 19:614-624.
109. Jahnke V.E., et al. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle 2012, 2:16.
110. Desguerre I., et al. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy. Muscle Nerve 2012, 45:803-814.
111. Wade A.J., et al. Muscle fibre type and aetiology of obesity. Lancet 1990, 335:805-808.
112. Kriketos A.D., et al. Muscle fibre type composition in infant and adult populations and relationships with obesity. Int. J. Obes. Relat. Metab. Disord. 1997, 21:796-801.
113. Thayer R., et al. A decade of aerobic endurance training: histological evidence for fibre type transformation. J. Sports Med. Phys. Fitness 2000, 40:284-289.
114. Goodyear L.J., Kahn B.B. Exercise, glucose transport, and insulin sensitivity. Annu. Rev. Med. 1998, 49:235-261.
115. Albright A., et al. American College of Sports Medicine position stand. Exercise and type 2 diabetes. Med. Sci. Sports Exerc. 2000, 32:1345-1360.
116. Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127:1109-1122.
117. Um J.H., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
118. Narkar V.A., et al. AMPK and PPARδ agonists are exercise mimetics. Cell 2008, 134:405-415.
119. Pokrywka A., et al. Metabolic modulators of the exercise response: doping control analysis of an agonist of the peroxisome proliferator-activated receptor delta (GW501516) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). J. Physiol. Pharmacol. 2014, 65:469-476.
120. Hardman S.E., et al. The effects of age and muscle contraction on AMPK activity and heterotrimer composition. Exp. Gerontol. 2014, 55:120-128.
121. Bujak A.L., et al. Reduced skeletal muscle AMPK and mitochondrial markers do not promote age-induced insulin resistance. J. Appl. Physiol. (1985) 2014, 117:171-179.